Home/Filings/4/0001214659-24-004795
4//SEC Filing

Schobel Alexander Mark 4

Accession 0001214659-24-004795

CIK 0001398733other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 2:30 PM ET

Size

4.9 KB

Accession

0001214659-24-004795

Insider Transaction Report

Form 4
Period: 2024-03-15
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
  • Sale

    Common Stock

    2024-03-15$6.00/sh50,000$300,000984,476 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 6, 2023.

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1
  • filerCIK 0001406836

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 2:30 PM ET
Size
4.9 KB